Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Pharmacoeconomics research

use managed-care data with caution

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Pharmacoeconomics research. Pharmacoecon. Outcomes News 241, 2 (1999). https://doi.org/10.1007/BF03275251

    Download citation

    Keywords

    • Respiratory Syncytial Virus
    • Outcome News
    • Health Insurance Coverage
    • Respiratory Syncytial Virus Infection
    • Great Caution